Calamos Advisors’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-300,000
Closed -$38K 653
2017
Q3
$38K Buy
+300,000
New +$2.99M ﹤0.01% 612

Calamos Advisors's IMMU Position: Q4 2020 in Review

Calamos Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 94,422 shares — an estimated $8.03M sold.

Calamos Advisors first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $8.03M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Calamos Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Calamos Advisors sold 94,422 Immunomedics Inc shares in Q4 2020, an estimated $8.03M.
  • Calamos Advisors first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Calamos Advisors's Immunomedics Inc position peaked at $8.03M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Calamos Advisors's 13F filing for Q4 2020, filed 27 Jan 2021.